Literature DB >> 67079

A unique property of fetal bovine serum: high levels of protein-glutathione mixed disulfides.

E A Bump, D J Reed.   

Abstract

Fetal bovine serum has been reported to delay or inhibit "spontaneous" neoplastic transformation in vitro as compared with all other sera tested. The present results indicate that fetal bovine serum is also unique in containing high levels of protein-glutathione mixed disulfides (3 to 7 microng glutathione as mixed disulfide per ml serum). The level of mixed disulfide appears to vary in accordance with the period of gestation of the fetal calves used to prepare the serum, decreasing below detectable levels (less than 0.2 microng per ml) with near-term fetal calves. Calf, adult bovine, fetal horse, and swine sera did not contain detectable levels of this type of mixed disulfide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67079     DOI: 10.1007/BF02615075

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  10 in total

1.  On the sulfhydryl group of human plasma albumin.

Authors:  T P KING
Journal:  J Biol Chem       Date:  1961-02       Impact factor: 5.157

2.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

Authors:  F Tietze
Journal:  Anal Biochem       Date:  1969-03       Impact factor: 3.365

Review 3.  The sulfhydryl group and carcinogenesis.

Authors:  J S Harington
Journal:  Adv Cancer Res       Date:  1967       Impact factor: 6.242

4.  Comparative effects of mare, stallion, gelding horse, and fetal bovine sera on neoplastic transformation in vitro.

Authors:  V J Evans; F M Price; K K Sanford; H A Kerr; S L Handleman
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

5.  A specific and sensitive assay for disulfides.

Authors:  W L Zahler; W W Cleland
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

6.  Comparative effects of horse, calf, and fetal serums on chromosomal characteristics and neoplastic conersion of mouse embryo cells in vitro.

Authors:  J T Mitchell; W F Andresen; V J Evans
Journal:  J Natl Cancer Inst       Date:  1969-05       Impact factor: 13.506

7.  Thin-layer chromatographic separation of cystine and the N-ethylmaleimide adducts of cysteine and glutathionen.

Authors:  B States; S Segal
Journal:  Anal Biochem       Date:  1969-02       Impact factor: 3.365

8.  Effect of serum on spontaneous neoplastic transformations in vitro.

Authors:  V J Evans; W F Andresen
Journal:  J Natl Cancer Inst       Date:  1966-08       Impact factor: 13.506

9.  Characterization and spontaneous neoplastic transformation of mouse embryo cells isolated and continuously cultured in vitro in chemically defined medium NCTC 135.

Authors:  W F Andresen; F M Price; J L Jackson; T B Dunn; V J Evans
Journal:  J Natl Cancer Inst       Date:  1967-02       Impact factor: 13.506

10.  Effect of horse serum, fetal calf serum, calf serum, bovine serum, and fetulin on neoplastic conversion and chromosomes of mouse embryo cells in vitro.

Authors:  R Parshad; K K Sanford
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

  10 in total
  3 in total

1.  Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.

Authors:  Jade J Welch; Ria J Swanekamp; Christiaan King; David A Dean; Bradley L Nilsson
Journal:  ACS Med Chem Lett       Date:  2016-03-30       Impact factor: 4.345

2.  Glutathione catabolism by Treponema denticola impacts its pathogenic potential.

Authors:  Lianrui Chu; Yimin Wu; Xiaoping Xu; Linda Phillips; David Kolodrubetz
Journal:  Anaerobe       Date:  2020-02-07       Impact factor: 3.331

3.  The effect of Nrf2 deletion on the proteomic signature in a human colorectal cancer cell line.

Authors:  Omid Cheraghi; Bahareh Dabirmanesh; Farideh Ghazi; Massoud Amanlou; Mona Atabakhshi-Kashi; Yaghoub Fathollahi; Khosro Khajeh
Journal:  BMC Cancer       Date:  2022-09-13       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.